Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT04284657 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT04284657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04284657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
January 30, 2019
Completion date
August 4, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney disease